Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
CAMBRIDGE, Mass., Aug. 6, 2013 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), an emerging biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat debilitating and often fatal rare diseases, announced today that the company will participate in the Canaccord Genuity 33rd Annual Growth Conference. Craig Fraser, President of Aegerion, is scheduled to present on Thursday, August 15, 2013 at 9:00 a.m. ET.
Help employers find you! Check out all the jobs and post your resume.
CAMBRIDGE, Mass., Aug. 6, 2013 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), an emerging biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat debilitating and often fatal rare diseases, announced today that the company will participate in the Canaccord Genuity 33rd Annual Growth Conference. Craig Fraser, President of Aegerion, is scheduled to present on Thursday, August 15, 2013 at 9:00 a.m. ET.
Help employers find you! Check out all the jobs and post your resume.
